Even AbbVie CEO can’t confirm Rinvoq’s sales as FDA mulls JAK label
Even AbbVie CEO can’t confirm Rinvoq’s sales as FDA mulls [...]
Even AbbVie CEO can’t confirm Rinvoq’s sales as FDA mulls [...]
AbbVie’s Vraylar turns in mixed results in depression, but pharma [...]
Pacira panel takes on uncomfortable women’s health topics to help [...]
Merck’s big earnings in Q3 play second fiddle to enthusiasm [...]
Alnylam founding CEO Maraganore steps down after pioneering RNA interference [...]
Up to 50M J&J COVID doses sit idle at Emergent [...]
As Lilly gears up for key 2022 launches, Trulicity, Taltz [...]
Democrats opposed to drug price reform are among those who [...]
Catalent antes up $230M to expand Maryland viral vector manufacturing [...]
Arrowhead takes aim at Wisconsin for $250M manufacturing plant: report [...]